- Home
- LUCY vs NXPL Comparison
LUCY vs NXPL Comparison
Compare LUCY & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCY
- NXPL
- Stock Information
- Founded
- LUCY 2017
- NXPL 1997
- Country
- LUCY United States
- NXPL United States
- Employees
- LUCY N/A
- NXPL N/A
- Industry
- LUCY Ophthalmic Goods
- NXPL Telecommunications Equipment
- Sector
- LUCY Health Care
- NXPL Telecommunications
- Exchange
- LUCY Nasdaq
- NXPL Nasdaq
- Market Cap
- LUCY 8.7M
- NXPL 22.8M
- IPO Year
- LUCY 2022
- NXPL N/A
- Fundamental
- Price
- LUCY $1.86
- NXPL $0.75
- Analyst Decision
- LUCY
- NXPL
- Analyst Count
- LUCY 0
- NXPL 0
- Target Price
- LUCY N/A
- NXPL N/A
- AVG Volume (30 Days)
- LUCY 657.6K
- NXPL 333.1K
- Earning Date
- LUCY 11-11-2025
- NXPL 11-13-2025
- Dividend Yield
- LUCY N/A
- NXPL N/A
- EPS Growth
- LUCY N/A
- NXPL N/A
- EPS
- LUCY N/A
- NXPL N/A
- Revenue
- LUCY $1,978,018.00
- NXPL $58,766,000.00
- Revenue This Year
- LUCY $149.32
- NXPL N/A
- Revenue Next Year
- LUCY $400.00
- NXPL N/A
- P/E Ratio
- LUCY N/A
- NXPL N/A
- Revenue Growth
- LUCY 29.30
- NXPL N/A
- 52 Week Low
- LUCY $1.57
- NXPL $0.43
- 52 Week High
- LUCY $10.40
- NXPL $2.30
- Technical
- Relative Strength Index (RSI)
- LUCY 44.02
- NXPL 44.61
- Support Level
- LUCY $1.80
- NXPL $0.78
- Resistance Level
- LUCY $2.05
- NXPL $1.10
- Average True Range (ATR)
- LUCY 0.12
- NXPL 0.07
- MACD
- LUCY -0.01
- NXPL -0.02
- Stochastic Oscillator
- LUCY 29.03
- NXPL 12.33
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.